Inventor · disambiguated record
Peter A. Seubert
Also filed as: SEUBERT PETER · SEUBERT PETER A · SEUBERT PETER ANDREW
30 granted patents·13 pending applications·2,373 citations·filing 1990–2024
98Inventor score
Files withELAN PHARM INC9ATHENA NEUROSCIENCES INC7PROTHENA BIOSCIENCES LTD7SCHENK DALE B6PROTHENA THERAPEUTICS LTD3
Top patents by PatentIndex Score
43 records- 0198US5721130AAntibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of βAPPATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 24, 1998·244 cites·14 claims
- 0298US5593846AMethods for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES·Filed 1995·Granted Jan 14, 1997·482 cites·16 claims
- 0398US5441870AMethods for monitoring cellular processing of β-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1992·Granted Aug 15, 1995·316 cites·26 claims
- 0497US7928203B2Chimeric, humanized, or human antibody 2A4ELAN PHARM INC·Filed 2008·Granted Apr 19, 2011·38 cites·3 claims
- 0596US10752679B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Aug 25, 2020·11 cites·30 claims
- 0696US10501531B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 10, 2019·16 cites·26 claims
- 0796US5605811AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 25, 1997·180 cites·7 claims
- 0896US5604102AMethods of screening for β-amyloid peptide production inhibitorsATHENA NEUROSCIENCES INC·Filed 1993·Granted Feb 18, 1997·165 cites·19 claims
- 0995US6114133AMethods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)ELAN PHARM INC·Filed 1994·Granted Sep 5, 2000·187 cites·20 claims
- 1094US12195525B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 14, 2025·1 cites·20 claims
- 1194US5837672AMethods and compositions for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 17, 1998·185 cites·14 claims
- 1293US6284221B1Method for identifying β-amyloid peptide production inhibitorsELAN PHARM INC·Filed 1996·Granted Sep 4, 2001·132 cites·9 claims
- 1393US2025268999A1Treatment and Prophylaxis of AmyloidosisPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 1492US11492393B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Nov 8, 2022·2 cites·14 claims
- 1591US8404815B2Chimeric, humanized, or human antibody 2A4SCHENK DALE B·Filed 2011·Granted Mar 26, 2013·8 cites·3 claims
- 1690US8791243B2Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2008·Granted Jul 29, 2014·8 cites·17 claims
- 1790US8268973B2Anti-amyloid antibodiesSCHENK DALE B·Filed 2011·Granted Sep 18, 2012·7 cites·18 claims
- 1890US6018024AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinELAN PHARM INC·Filed 1997·Granted Jan 25, 2000·69 cites·3 claims
- 1986US6717031B2Method for selecting a transgenic mouse model of alzheimer's diseaseFiled 1998·Granted Apr 6, 2004·50 cites·56 claims
- 2085US7186881B2Testing compounds for effects on synaptophysin in transgenic mice expressing an Alzheimer's disease FAD DNA sequenceELAN PHARM INC·Filed 2003·Granted Mar 6, 2007·23 cites·10 claims
- 2185US6610493B1Screening compounds for the ability to alter the production of amyloid-β peptideBRIGHAM & WOMENS HOSPITAL·Filed 1996·Granted Aug 26, 2003·69 cites·21 claims
- 2282US5424205AAmyloidin protease and uses thereofATHENA NEUROSCIENCES INC·Filed 1993·Granted Jun 13, 1995·71 cites·11 claims
- 2381US8636981B2Detection of amyloid deposits using anti-amyloid antibodiesSCHENK DALE B·Filed 2011·Granted Jan 28, 2014·2 cites·21 claims
- 2478US2023340094A1Tau ImmunotherapyPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 2577US7811769B2Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tauELAN PHARM INC·Filed 2004·Granted Oct 12, 2010·2 cites·5 claims
- 2677US7427392B1Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tauELAN PHARM INC·Filed 1995·Granted Sep 23, 2008·22 cites·8 claims
- 2777US5292652AAmyloidin protease and uses thereofATHENA NEUROSCIENCES INC·Filed 1991·Granted Mar 8, 1994·36 cites·15 claims
- 2876US5118606AMethods for detecting cellular pathology by assaying spectrin and spectrin breakdown productsUNIV CALIFORNIA·Filed 1990·Granted Jun 2, 1992·43 cites·35 claims
- 2973US7700309B2Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (X->41) and tauELAN PHARM INC·Filed 2004·Granted Apr 20, 2010·1 cites·18 claims
- 3071US11643457B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2019·Granted May 9, 2023·0 cites·12 claims
- 3170US8357781B2Neuroactive fragments of APPJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2007·Granted Jan 22, 2013·3 cites·2 claims
- 3270US2021008185A1Treatment and Prophylaxis of AmyloidosisPROTHENA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 3367US2014134103A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2013·Application pending·0 cites
- 3466US2004253643A1Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-beta peptide (x->41) and tauFiled 2004·Application pending·0 cites
- 3565US2018360934A1Treatment and prophylaxis of amyloidosisPROTHENA THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 3665US2015158937A1Treatment and prophylaxis of amyloidosisONCLAVE THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 3764US2012321555A1Treatment and prophylaxis of amyloidosisSCHENK DALE B·Filed 2012·Application pending·0 cites
- 3859US2008279873A1Active immunization to generate antibodies to soluble a-betaSEUBERT PETER A·Filed 2008·Application pending·0 cites
- 3959US2017081396A1Treatment and prophylaxis of amyloidosisPROTHENA THERAPEUTICS LTD·Filed 2016·Application pending·0 cites
- 4053US2004213800A1Active immunization to generate antibodies to soluble A-betaFiled 2004·Application pending·0 cites
- 4153US2006188512A1Active immunization to generate antibodies to solble a-betaYEDNOCK TED·Filed 2004·Application pending·0 cites
- 4249US7993627B2Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammalELAN PHARM INC·Filed 2002·Granted Aug 9, 2011·0 cites·5 claims
- 4340US2006240486A1Immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodiesJOHNSON-WOOD KELLY L·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter A. Seubert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →